Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Hyperlipidemia in children: Unsolved problems
https://doi.org/10.21508/1027-4065-2022-67-6-40-45
Abstract
The article presents literature review findings on the prevalence, diagnosis, and treatment of hyperlipidemia, including familial hypercholesterolemia in children. It is noted that the number of patients with hyperlipidemia continues to grow throughout the world. As before, hyperlipidemias are considered risk factors for the development of cardiovascular diseases and the cause of high mortality in different countries of the world. Attention is drawn to the possibility of atherosclerotic lesions of the heart vessels in young people and adolescents. Diseases in children (diabetes mellitus, obesity, hypothyroidism, renal pathology, etc.) have been noted, which necessitate diagnosing hyperlipidemia. There are no clear guidelines for pediatricians regarding cholesterol screening and timing of therapy initiation.
About the Authors
M. I. Nikitina
Samara State Medical University
Russian Federation
Russian Federation
Samara
G. V. Santalova
Samara State Medical University
Russian Federation
Russian Federation
Samara
References
1. Catapano A.L., Graham I., De Backer G., Wiklund O., Chapman M.J., Drexel H., et al; ESC Scientific Document Group. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016; 37(39): 2999–3058. DOI: 10.1093/eurheartj/ehw272
2. Mărginean C.O., Melit L.E., Dobreanu M., Mărginean M.O. Type V hypertriglyceridemia in children, a therapeutic challenge in pediatrics: A case report and a review of the literature. Medicine 2017; 96(51): e8864. DOI: 10.1097/md.0000000000008864
3. Ramaswamia U., Humphriesb S. E., Priestley-Barnhamc L., Greend P., Walde D.S., Cappsf N. Current management of children and young people with heterozygous familial hypercholesterolaemia — HEART UK statement of care. Atherosclerosis 2019; 290: 1–8. DOI: 10.1016/j.atherosclerosis.2019.09.005
4. Collins R., Reith C., Emberson J., Armitage J., Baigent C., Blackwell L. et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016; 388: 2532–2561. DOI: 10.1016/S0140–6736(16)31357–5
5. Watts G.F., Gidding S., Wierzbicki A.S., Toth P.P., Alonso R., Brown W.V. et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol 2014; 171(3): 309–325. DOI: 10.1016/j.Ùcard.2013.11.025
6. Goldberg A., Hopkins P., Toth P., Ballantyne C., Robinson J., Daniels S. et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5: 133–140. DOI: 10.1016/j.jacl.2011.04.003
7. Ezhov M.V., Sergienko I.V., Rozhkova T.A., Kukharchuk V.V., Konovalov G.A., Meshkov A.N. et al.The Russian references on diagnostics and treatment of a family hypercholesterolaemia. Ateroskleroz i dislipidemii 2016; 25(4): 21–29. (in Russ.)
8. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O. et al.; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–818. DOI: 10.1093/eurheartj/ehr158
9. Coakley J.C. Lipids in Children and Links to Adult Vascular Disease. Clin Biochem Rev 2018; 39(3): 65–76
10. Ezhov M.V., Bazhan S.S., Yershova A.I., Meshkov A.N., Sokolov A.A., Kukharchuk V.V. et al. Clinical recommendations for familial hypercholesterolemia. Ateroskleroz i dislipidemii 2019; 34: 5–43. (in Russ.)
11. Ference B., GinsbergH., Graham I., Ray K., Packard C., Bruckert E. et al. Low-density lipoproteins cause atheroscle-rotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017; 38(32): 2459–2472. DOI: 10.1093/eurheartj/ehx144
12. Rubanenko O.A., Kirichenko N.A., Fatenkov O.V. Correction of lipid and hemostatic disorders in patients at high risk of cardiovascular death. Scie Innovat Med 2016; 1(1): 41–45. (in Russ.) DOI: 10.35693/2500–1388–2016–0–1–41–45
13. Wiegman A., Gidding S., Watts G., Chapman M., Ginsberg H., Cuchel M. et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing. Eur Heart J 2015; 36: 2425–2437. DOI: 10.1093/eurheartj/ehv157
14. Harada-Shiba M., Ohta T., Ohtake A., Ogura M., Dobashi K., Nohara A. et al.; Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia. Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb 2018; 25(6): 539–553. DOI: 10.5551/jat.CR002
15. Stempel H., Dodge A., Marriott E., Peterson A.L. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic. J Pediatr 2016; 178: 285–287. DOI: 10.1016/j.jpeds.2016.08.016
16. Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S. et al.; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34(45): 3478–90a. DOI: 10.1093/eurheartj/eht273
17. Fredrickson D.S., Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31: 321–327. DOI: 10.1161/01.cir.31.3.321
18. Justo R.N. Management of familial hypercholesterolaemia in children and adolescents. J Paediatr Child Health 2012; 48(2): E53–58. DOI: 10.1111/j.1440–1754.2011.02206. x
19. Ershova A.I., Al Rashi D.O., Ivanova A.A., Aksenova Yu.O., Meshkov A.N. Secondary hyperlipidemias: etiology and pathogenesis. Rossiiskii kardiologicheskii zhurnal 2019; 5:74–81. (in Russ.)
20. Turkinа T.I., Shcherbakova M.Yu. Dyslipidemia features in children. Ratsional’naya farmakoterapiya v kardiologii 2011; 7(1): 65–69. (in Russ.) DOI: 10.20996/1819–6446–2011–7–1–65–69
21. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5(Suppl 5): S213–56. DOI: 10.1542/peds.2009–2107C
22. DeSantes K., Dodge A., Eickhoff J., Peterson A.L. Improving Universal Pediatric Lipid Screening. J Pediatr 2017; 188: 87–90. DOI: 10.1016/j.jpeds.2017.05.030
23. Susekov A.V., Jafarov A.A., Scherbakova M.Yu., Meshkov A.N. Regression of a xanthomatosis at the 12-year-old patient with a homozygous form of a family hypercholesterolaemia: clinical case. Consilium Medicum. Pediatriya 2016; 3: 103–108. (in Russ.)
24. Kusters D.M., de Beaufort C., Widhalm K., Guardamagna O., Bratina N., Ose L., Wiegman A. Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child 2012; 97(3): 272–276. DOI:10.1136/archdischild-2011–300081
25. Wald D.S., Bestwick J.P., Morris J.K., Whyte K., Jenkins L., Wald N.J. Child-Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med 2016; 375(17): 1628–1637. DOI: 10.1056/NEJMoa1602777
26. D’Innocenzo S., Biagi C., Lanari M. Obesity and the Mediterranean Diet: A Review of Evidence of the Role and Sustainability of the Mediterranean Diet. Nutrients 2019; 11(6): 1306. DOI: 10.3390/nu11061306
27. Farajian P., Risvas G., Karasouli K., Pounis G.D., Kastorini C.M., Panagiotakos D.B., Zampelas A. Very high childhood obesity prevalence and low adherence rates to the Mediterra-nean diet in Greek children: the GRECO study. Atherosclerosis 2011; 217(2): 525–530. DOI: 10.1016/j.atherosclerosis.2011.04.003
28. Belyaeva L.E. Can regular consumption of «functional food» slow down the rate of atherogenesis? Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta 2012; 11(3): 15–27. (in Russ.)
29. Vasilenko V.S., Semenova E.S., Semenova Yu.B. Blood lipids in athletes depending on the orientation of the training process. Pediatr 2017; 8(2): 10–14. (in Russ.) DOI: 10.17816/PED8210–14
30. Dautova A.Z., Shamratova V.G. The level of lipids in the blood of male athletes depending on sports specialization. Nauka i sport: sovremennye tendencii 2021; 9(3): 6–14. (in Russ.)
31. Pizova N.V., Druzhinin D.S. Сarotid atherosclerotic lesion in young patients. Klinirtsist 2014; 8(1): 28–33. (in Russ.) DOI: 10.17650/1818–8338–2014–1–28–33
32. Peterkova V.A., Vasyukova O.V. About the new classification of obesity in the children and adolescents. Problemy endokrinologii 2015; 61(2): 39–44. (in Russ.) DOI: 10.14341/probl201561239–44
33. Kukharchuk V.V., Ezhov M.V., Sergienko I.V., Arabidze G.G., Balakhonova T.V., Gurevich V.S. et al. Eurasian association of cardiology (EAC)/Russian national atherosclerosis society (RNAS, RUSSIA) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Evraziiskii kardiologicheskii zhurnal 2020; 2: 6–29. (in Russ.) DOI: 10.38109/2225–1685–2020–2–6–29]
34. Shah A.S., Wilson D.P. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol 2015; 9(5 Suppl): S20–28. DOI: 10.1016/j.jacl.2015.04.004
35. Valaiyapathi B., Ashraf A.P. Hospital Management of Severe Hypertriglyceridemia in Children. Curr Pediatr Rev 2017; 13(4): 225–231. DOI: 10.2174/1573400514666180117092707
36. European Association for Cardiovascular Prevention & Rehabilitation; Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O. et al.; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–1818. DOI: 10.1093/eurheartj/ehr158
37. Peterkova V.A., Vasyukova O.V. About the new classification of obesity in the children and adolescents. Problemy endokrinologii 2015; 61(2): 39–44. (in Russ.) DOI: 10.14341/probl201561239–44
Review
For citations:
Nikitina M.I., Santalova G.V. Hyperlipidemia in children: Unsolved problems. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(6):40-45. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-6-40-45
Views:
673
Email this article 